Kozak & Associates, Inc. Abb Vie Inc. Transaction History
Kozak & Associates, Inc.
- $430 Million
- Q4 2024
A detailed history of Kozak & Associates, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Kozak & Associates, Inc. holds 1,721 shares of ABBV stock, worth $347,779. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,721
Previous 1,682
2.32%
Holding current value
$347,779
Previous $332,000
8.13%
% of portfolio
0.07%
Previous 0.08%
Shares
12 transactions
Others Institutions Holding ABBV
# of Institutions
4,095Shares Held
1.28BCall Options Held
16.7MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA173MShares$35 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.6 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$16.1 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$10.5 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$8.02 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $357B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...